Related Experiment Video
Updated: Jan 19, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.9K
Adjuvant interferon therapy for malignant melanoma: the debate
1State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, PR China.
Chinese Journal of Cancer
|October 29, 2010
Summary
High-dose interferon alpha-2b (HDI) is approved for high-risk melanoma adjuvant therapy. However, its effectiveness on overall survival remains debated, necessitating individualized patient treatment decisions.
Area of Science:
- Oncology
- Immunotherapy
- Melanoma Research
Background:
- High-dose interferon alpha-2b (HDI) was approved by the FDA for adjuvant therapy in high-risk melanoma based on the ECOG 1684 trial.
- Controversies persist regarding interferon (IFN) adjuvant therapy for melanoma due to inconsistent results from subsequent clinical trials.
Purpose of the Study:
- To review the evidence and controversies surrounding adjuvant interferon therapy for melanoma.
- To discuss the implications for clinical practice and individualized patient care.
Main Methods:
- Review of clinical trial data, including the ECOG 1684 trial.
- Analysis of relapse-free survival (RFS) and overall survival (OS) data from various interferon therapy trials.
Main Results:
- Adjuvant interferon therapy has shown benefits in relapse-free survival (RFS) for melanoma patients.
- A significant impact on overall survival (OS) has not been consistently confirmed across trials.
- Optimal interferon timing, dosage, and type remain undefined.
Conclusions:
- Adjuvant interferon treatment is best utilized within randomized clinical trials at specialized centers.
- Treatment decisions for adjuvant interferon alfa-2b should be individualized, considering potential benefits, side effects, and patient-specific factors.
- Further research is needed to identify prognostic factors for individualized melanoma therapy.
Related Concept Videos
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:30Cancer Vaccines
976
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
976